Literature DB >> 7504259

Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis.

J M McCarthy1, V A White, G Harris, K B Simons, J Kennerdell, J Rootman.   

Abstract

Idiopathic sclerosing inflammation of the orbit is clinically characterized by an insidious, chronic and progressive fibrosing process damaging orbital structures through entrapment and mass effect. Histologically, desmoplasia and a sparse infiltrate of lymphocytes, histiocytes, plasma cells, and occasional neutrophils and eosinophils are seen. An immune pathogenesis is suspected but presently poorly understood. To characterize the inflammatory infiltrate and to compare orbital and other inflammatory fibrosing lesions, immunoperoxidase studies using the streptavidin method were performed on 16 formalin or Bouins' fixed, paraffin-embedded orbital biopsy specimens and six specimens of retroperitoneal fibrosis. Positive staining of orbital tissue occurred as follows: T-cells (UCHL-1) 94% of cases, B-cells (L26) 40%, tissue macrophages (KP-1) 56%, HLA Dr positive antigen presenting cells and activated T-cells (LN3) 44%, and immunoglobulins (kappa, 80%; lambda, 63%, IgG, 73%, IgA, 44% and IgM, 31%). Results were strikingly similar for retroperitoneal fibrosis. These findings imply a cell mediated pathogenesis in idiopathic sclerosing inflammation of the orbit that is similar to retroperitoneal fibrosis and suggest therapeutic potential for agents modifying this facet of the immune system.

Entities:  

Mesh:

Year:  1993        PMID: 7504259

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

1.  Idiopathic sclerotic inflammation of the orbit with left optic nerve compression in a patient with multifocal fibrosclerosis.

Authors:  G J Schaffler; J Simbrunner; H Lechner; G Langmann; H Stammberger; A Beham; F Ebner
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Angiocentric lesions of the head and neck.

Authors:  Cynthia M Magro; Molly Dyrsen
Journal:  Head Neck Pathol       Date:  2008-05-27

Review 3.  Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?

Authors:  D Lindfield; K Attfield; A McElvanney
Journal:  Eye (Lond)       Date:  2012-02-03       Impact factor: 3.775

4.  Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor.

Authors:  Puneet S Braich; Robin K Kuriakose; Naveen S Khokhar; Jared C Donaldson; Timothy J McCulley
Journal:  Int Ophthalmol       Date:  2017-06-20       Impact factor: 2.031

5.  Not a Tumor-Nonspecific Orbital Inflammation.

Authors:  James A Garrity
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-02

6.  Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes.

Authors:  B N Swamy; P McCluskey; A Nemet; R Crouch; P Martin; R Benger; R Ghabriel; D Wakefield
Journal:  Br J Ophthalmol       Date:  2007-07-09       Impact factor: 4.638

Review 7.  [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].

Authors:  S E Coupland
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

8.  Idiopathic sclerosing orbital pseudotumor in seven cats.

Authors:  F Mark Billson; Tammy Miller-Michau; John R B Mould; Michael G Davidson
Journal:  Vet Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 1.644

9.  Idiopathic sclerosing inflammation presenting as sinusitis.

Authors:  Henry P Barham; Megan K Dishop; Jeremy D Prager
Journal:  Allergy Rhinol (Providence)       Date:  2012-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.